BA Stock: Buy or Sell? Price Target & Forecast

BA Boeing Co As of Sep 15, 2026

$210.27

Large-cap defense/commercial aircraft manufacturer; elevated valuation amid recovery narrative and defense tailwinds.

Setup: Recovery / Cyclical / Defense Beneficiary Confidence: 58 Horizon: 3-6 months Risk: medium-high Category: Large Cap

🔒 Trade Plan — entry · target · stop

Entry Zone

$•••–•••

Target

$•••

Stop Loss

$•••

Risk / Reward

•.• : 1

Unlock the exact levels — free →

A free account reveals BA's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Defense spending tailwinds (KC-46 contract win $13.4B); commercial fleet modernization driving cabin seating/interiors demand; 10%+ revenue growth; insider buying 71 buys vs 28 sells signals confidence; 737 MAX production ramp and operational recovery narrative intact.

▼ Bear Case

Extreme valuation multiples (P/E 68x, forward 74x, EV/EBITDA 31.6x) far exceed historical and peer norms; razor-thin net margin 2.5% and operating margin 4.79% limit earnings power; quick ratio 0.41 signals liquidity tightness; stock down 17% from 52-week high despite 'recovery'—momentum may be exhausted.

Valuation

OVERVALUED on absolute multiples; fair on recovery thesis optionality — score 35/100

P/E 68x and forward P/E 74x are 2–3x typical aerospace peer averages and historical BA average ~18–22x. P/B 31.2x is extreme for a manufacturer with 4.95 tangible book value. EV/EBITDA 31.6x and price-to-FCF 37.5x both suggest market pricing in sustained margin expansion and/or significant earnings accretion. P/S 1.86x is reasonable for defense/aerospace, but multiples stack into a premium that leaves limited margin for error.

Technical Levels

Support · $207.98 (Today's low / near-term support) · $200.00 (Psychological / 1-month support) · $185.00 (Minor trend support) · $176.77 (52-week low)

Resistance · $211.89 (Today's high) · $220.00 (1-month resistance) · $235.00 (Intermediate resistance / target) · $254.35 (52-week high)

Financial Health

Score 62/100. Liquidity acceptable but not robust; quick ratio 0.41 suggests working capital constraints. Margins are razor-thin (4.79% operating, 2.5% net), limiting earning power and leaving little cushion for cost overruns or revenue shortfalls. Debt structure unknown; monitor leverage closely given capital intensity of aerospace manufacturing.

Catalysts

Defense contract execution (KC-46, other)	Ongoing through 2025	high
737 MAX production ramp updates / earnings	Q4 2024 earnings + quarterly updates	high
Commercial aircraft cabin seating market growth materialization	2025–2026 (multi-year)	medium
Geopolitical escalation or defense budget cuts	Unpredictable	high
Recession / recession fears impacting airline capex	Unpredictable	high

Risk Flags

P/E 68x and forward P/E 74x are historically elevated; recovery pricing may already be baked in.

Net margin 2.5% and operating margin 4.79% are thin; earnings leverage limited if revenue growth stalls.

Quick ratio 0.41 indicates potential working capital pressure; monitor cash generation closely.

Price is 17% below 52-week high; pullback may reflect profit-taking or sentiment rotation rather than fresh catalyst.

Forward P/E 74x suggests market pricing in significant EPS accretion over next 1-2 years; execution risk is high.

Defense/aerospace cyclicality: geopolitical risk, defense budget delays, or commercial airline capex weakness could reverse tailwinds.

See BA's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock BA free →

More Analyses

AMD

Advanced Micro Devices Inc

Micron Technology Inc

CRM

Salesforce Inc

Goldman Sachs Group Inc

Visa Inc

Mastercard Inc

BA FAQ

Is BA a buy right now?

Boeing Co's current read is a Recovery / Cyclical / Defense Beneficiary setup with 58 confidence over a 3-6 months horizon. Valuation: OVERVALUED on absolute multiples; fair on recovery thesis optionality. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is BA overvalued?

OVERVALUED on absolute multiples; fair on recovery thesis optionality (valuation score 35/100). P/E 68x and forward P/E 74x are 2–3x typical aerospace peer averages and historical BA average ~18–22x. P/B 31.2x is extreme for a manufacturer with 4.95 tangible book value. EV/EBITDA 31.6x and price-to-FCF 37.5x both suggest market pricing in sustained margin expansion and/or significant earnings accretion. P/S 1.86x is reasonable for defense/aerospace, but multiples stack into a premium that leaves limited margin for error.

What are the risks of buying BA?